Citron research and inovio
Webinovio pharmaceuticals, inc. et al Filing 53 MEMORANDUM SIGNED BY HONORABLE GERALD J. PAPPERT ON 6/18/20. 6/18/20 ENTERED AND COPIES E-MAILED. WebCitron Research is a research company that has been publishing reports for over 14 years which are centered on fraudulent and terminal business-models.
Citron research and inovio
Did you know?
WebMar 12, 2024 · Inovio Pharmaceuticals Inc (NASDAQ: INO) partnered with Beijing Advaccine Biotechnology Co. to advance the development of INO-4800 which is their … WebFeb 16, 2024 · (Am. Compl. at ¶ 101.) Inovio's response to Citron Research revealed that it had not constructed a vaccine in three hours, as Kim had claimed; rather, it conceded …
WebApr 30, 2024 · Citron describes Inovio’s management team as “a group of charlatans.” The firm drew attention to a 60 Minutes interview with Kate Broderick, the company’s SVP of … WebSep 17, 2024 · Citron Research, another short seller, had compared Inovio to scandal-ridden Theranos earlier this year and called it “one of the longest running and most blatant stock promotion schemes ever witnessed.” The stock has tanked more than 41% since hitting its all-time high on June 29 th this year.
WebApr 30, 2024 · Citron Research is targeting another company. This time it's Inovio Pharmaceuticals, which the firm compared to Theranos during COVID-19. In a report posted on its website, Citron said that... WebSep 20, 2024 · Citron have in the past shortened 51 out of the S & P 500 companies and been short on Tesla, Nvdia, Shopify, Ubiquiti Networks, Facebook, Peloton, Inovio Pharmaceuticals, Inc., Hubspot, among...
WebMar 17, 2024 · According to the complaint, Citron Research on March 9 “exposed [the] Defendants’ misstatements,” calling for a Securities and Exchange Commission investigation into the company’s claims. In response to this news, the lawsuit says, Inovio’s stock price fell from $18.72 per share to close at $9.83, with a similar trend continuing the ...
WebMay 20, 2024 · Benzinga has contacted Inovio for comment on the Citron report. About 90% Downside Likely For Inovio, Short Seller Says In a tweet, Citron assigned a $2 … solgar phytosterol complex 1000mg 100sWebMay 8, 2024 · Citron also questions Inovio’s claim that it designed a COVID-19 vaccine in 3 hours. Inovio has said it designed the vaccine quickly since all it needed to know was … solgar organic flaxseed oilWebSep 29, 2024 · Noted short seller Citron Research sees 83% downside risk (price target = $2) in Inovio Pharmaceuticals (INO-4.9%) on the heels of the FDA's partial clinical hold … solgar quercetin complex with ester-c reviewsWebMar 31, 2024 · The lawsuit states that on March 9, 2024, before trading commenced, Citron Research exposed Defendants' misstatements, calling for an SEC investigation into the Company's claim. In response,... smaditingWebJun 8, 2024 · However, this statement attracted critics, one of them being Citron Research. The short-seller accused Inovio of playing up this technology, ala shamed company Theranos, to artificially and ... solgar pectinWebApr 27, 2024 · BOSTON, April 27, 2024 (GLOBE NEWSWIRE) -- Today, research analyst Citron Research published a report calling Inovio (NASDAQ: INO) “The COVID-19 Version of Theranos,” in which Citron... solgar oyster shell calciumWebMar 9, 2024 · As if informed investors need any additional words of warning on high-risk companies caught up in the coronavirus frenzy, Citron Research tweeted this morning … solgar phosphatidylserine